64466-25-7

Basic information

• Product Name: [[μ-5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrinato(2-)]zinc(II)]
• Synonyms: [[μ-5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrinato(2-)]zinc(II)]
• CAS NO: 64466-25-7
• Molecular Weight: 910.27
• Mol File: 64466-25-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: [[μ-5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrinato(2-)]zinc(II)](CAS DataBase Reference)
• NIST Chemistry Reference: [[μ-5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrinato(2-)]zinc(II)](64466-25-7)
• EPA Substance Registry System: [[μ-5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrinato(2-)]zinc(II)](64466-25-7)

Safety Data

• Hazardous Substances Data: 64466-25-7(Hazardous Substances Data)

Usage

General Description

The chemical μ-5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrinato(2-)zinc(II), also known as ZnTMPyP, is a zinc complex of porphyrin. It is a type of synthetic compound that contains a zinc ion coordinated with a porphyrin ligand. ZnTMPyP has been studied for its potential use in photodynamic therapy, a cancer treatment that involves the use of light and a photosensitizing agent to kill cancer cells. It has also been investigated for its antioxidant and antibacterial properties. The compound's unique structure and properties make it a subject of interest in various fields of research, including medicine and materials science.

Upstream product

• 5970-45-6 zinc(II) acetate dihydrate 
• 22112-83-0 5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrin 
• 109-97-7 pyrrole 
• 1571-08-0 methyl 4-formylbenzoate 
• 7646-85-7 zinc(II) chloride 
• 67-56-1 methanol 
• 100685-55-0 zinc(II) sulfate monohydrate 
• 557-34-6 zinc diacetate 

Downstream Products

• 1245811-99-7 C₄₈H₃₆N₁₂O₄Zn 
• 916345-57-8 pyridine(tetramethyl 4,4',4'',4'''-porphyrin-5,10,15,20-tetrabenzoato)zinc(II) 

Relevant articles and documents

Photophysical properties and photodynamic therapy activity of a meso-tetra(4-carboxyphenyl)porphyrin tetramethyl ester-graphene quantum dot conjugate

Novel meso-tetra(4-carboxyphenyl)porphyrin tetramethyl ester metal derivatives were synthesised and characterized. These derivatives were interacted with graphene quantum dots (GDQs). Spectroscopic evidence that was obtained showed that the resultant conjugates were stable due to the strong π-π stacking interaction between the GQDs and the porphyrins. The fluorescence and singlet oxygen generating behaviour of the porphyrins and the nanoconjugates were investigated following incorporation. The dark toxicity and photodynamic therapy activities of the porphyrins and the nanoconjugates were successfully studied using MCF-7 breast cancer cells. Cell viability for the dark toxicity was more than 90% for all complexes. The PDT activities at the highest concentration of 120 μg ml?1 showed a decrease in cell viability down to 15.2% for the GaClTMPP-GQDs.

H2S-Activable MOF Nanoparticle Photosensitizer for Effective Photodynamic Therapy against Cancer with Controllable Singlet-Oxygen Release

Photodynamic therapy (PDT) has emerged as an important minimally invasive tumor treatment technology. The search for an effective photosensitizer to realize selective cancer treatment has become one of the major foci in recent developments of PDT technolo

Two new self-assemblies of two zinc porphyrin with isonicotinic acid by metal-ligand axial coordination and their applications in supramolecular solar cell

Two new self-assemblies based on two zinc porphyrins substituted at the meso-positions with different donor units (denoted as ZnP1 and ZnP2) and isonicotinic acid (A) by metal-ligand axial coordination have been designed and immobilized on the double-laye